The large tegument proteins of herpesviruses encode conserved cysteine proteases of unknown function. Here we show that BPLF1, the Epstein-Barr-virus-encoded member of this protease family, is a deneddylase that regulates virus production by modulating the activity of cullin-RING ligases (CRLs). BPLF1 hydrolyses NEDD8 conjugates in vitro, acts as a deneddylase in vivo, binds to cullins and stabilizes CRL substrates. Expression of BPLF1 alone or in the context of the productive virus cycle induces accumulation of the licensing factor CDT1 and deregulates S-phase DNA synthesis. Inhibition of BPLF1 during the productive virus cycle prevents cellular DNA re-replication and inhibits virus replication. Viral DNA synthesis is restored by overexpression of CDT1. Homologues encoded by other herpesviruses share the deneddylase activity. Thus, these enzymes are likely to have a key function in the virus life cycle by inducing a replication-permissive S-phase-like cellular environment.
1
. Ubiquitin conjugation is mediated by a cysteine-based enzymatic cascade that comprises an ATP-dependent activating enzyme (E1), a conjugating enzyme (E2) and a substrate-specific ligase (E3) that transfers the modifier to the acceptor protein 2 . The modification is reversed by deconjugases that hydrolyse the covalent bond formed between the modifier and the substrate 3 . Since the discovery of the ubiquitin conjugation system, similar pathways for the conjugation of ubiquitin-like proteins (UbLs), including NEDD8, ISG15, SUMO-1, SUMO-2, SUMO-3 and others, have been identified 4 . Modification by UbLs does not usually result in protein degradation, although important crosstalks have been highlighted by the demonstration that NEDD8 (ref. 5 ) and SUMO 6, 7 regulate the activity of certain E3s. Thus, the best-characterized substrates of NEDD8 conjugation are cullins that function as scaffolds for the assembly of cullin-RING ligases (CRLs) 8 . Neddylation is required for ligase activity and thereby controls the ubiquitylation and kinetics of degradation of CRL substrates 9 . Viruses exploit the ubiquitin and UbL signalling cascades in almost every step of their life cycle 10 . In addition, viruses manipulate innate and adaptive immune responses that are controlled by these modifications, including the production of interferons and immunoregulatory cytokines and the processing of viral proteins into antigenic peptides 11 . Interference strategies are epitomized by the capacity of viral proteins, such as the human papillomavirus E6, to bind cellular E3s and redirect their activity towards substrates whose destruction favours virus replication 12 . Deconjugases, such as the ubiquitin-specific protease USP7-HAUSP, are similarly targeted by herpes simplex virus (HSV) ICP0 (ref. 13 ) and Epstein-Barr virus (EBV) EBNA-1 (ref. 14) to alter the turnover of cellular regulators of DNA synthesis and apoptosis. Viruses also encode functional homologues of these enzymes that often share little homology with their cellular counterparts and are therefore attractive targets for selective inhibition 15 . EBV is a gammaherpesvirus that immortalizes B lymphocytes and is associated with human malignancies 16 . B-cell immortalization is caused by a latent infection in which viral proteins hijack signalling pathways controlling cell proliferation, differentiation and apoptosis 17 . While this phase of the virus life cycle is relatively well understood, much less is known about virus replication. Virus production is initiated by the immediate-early protein BZLF1, which transactivates viral and cellular promoters, leading to the sequential expression of genes involved in viral DNA synthesis, virus assembly and maturation 18 . In a similar manner to other herpesviruses, the productive cycle of EBV occurs in an S-phase-like cellular environment and activates ATM (ataxia telangiectasia mutated) and Chk2-dependent DNA damage responses 19 . BZLF1 induces this phenotype only in EBV-positive cells, suggesting that other viral proteins are involved.
With the use of a functional screen based on the co-expression of glutathione S-transferase (GST)-tagged EBV open reading frames (ORFs) with green fluorescent protein (GFP)-based ubiquitin and UbL reporters 
NEDD8
Figure 1 BPLF1 is a NEDD8-specific deconjugase. (a) Screen for EBV encoded ubiquitin-specific and UbL-specific deconjugases. A library of 88 EBV ORFs was tested for cleavage of ubiquitin-, ISG15-, NEDD8-, SUMO-1, SUMO-2, or SUMO-3-GFP-S-tag reporters in bacterial assays. Bacterial lysates containing equal GFP fluorescence units were fractionated by SDS-PAGE and western blots were probed with an S-tag-specific antibody. The percentage specific cleavage was calculated as 100 × (intensity of free GFP minus the background)/(total GFP intensity minus background). Specific deconjugases for ubiquitin = USP19, ISG15 = USP4, NEDD8 = NEDP1, SUMO-1, SUMO-2, SUMO-3 = SENP1 were used as positive controls. (b) BPLF1 cleaves ubiquitin-AMC (Ub-AMC) and NEDD8-AMC with equal efficiency. The indicated purified proteins (50 nM) we have discovered that the conserved cysteine protease encoded in the amino terminus of major tegument protein BPLF1 is a deneddylase that binds to cullins and regulates the activity of CRLs, leading to deregulation of the cell cycle. Inhibition of BPLF1 during the productive cycle severely diminishes the yield of viral DNA.
RESuLTS
The N terminus of BPLF1 encodes a NEDD8-specific deconjugase In search for EBV-encoded ubiquitin or UbL deconjugases we used a bacterial assay 20 in which plasmids encoding GST-tagged EBV ORFs were co-expressed together with reporter plasmids encoding GFP fused -tagged Cul1 or Cul4A and Flag-tagged BPLF1, NEDP1 or BPLF1 C61A were immunoprecipitated with anti-Myc (upper panels) or anti-Flag (lower panels) antibodies and western blots were sequentially probed with anti-Myc and antiFlag antibodies. Both cullins were co-immunoprecipitated by the wild-type and mutant BPLF1, whereas only a weak interaction was detected with NEDP1 (indicated by asterisks). Omission of the cysteine protease inhibitor NEM from the lysis buffer (-) did not affect the efficiency of co-immunoprecipitation of cullin with BPLF1. (c) BPLF1 binds to endogenously expressed cullins. Cul4A and BPLF1 were immunoprecipitated from lysates of HeLa cells transfected with Flag alone, Flag-BPLF1 or Flag-BPLF1 C61A using specific antibodies, and western blots were sequentially probed with antibodies against Cul4A, Flag and c-Myc. One representative experiment of three is shown. (d) Expression of the CRL substrates CDT1, Cdc25A, p27 and p21 was assayed in HeLa cells 48 h after transfection with BPLF1 or a control empty vector. The accumulation of CRL substrates in BPLF1-expressing cells was reversed in a dose-dependent manner by overexpression of NEDD8, whereas a mutant V5-NEDD8-VV, lacking the C-terminal Gly residue required for conjugation, and HA-ubiquitin had minor or no effects. One representative experiment of three is shown. Uncropped images of blots are shown in Supplementary Information, Fig. S6 .
nature cell biology VOLUME 12 | NUMBER 4 | APRIL 2010to either ubiquitin, ISG15, NEDD8, SUMO-1, SUMO-2 or SUMO-3. Cleavage of the reporters was assessed in western blots by the appearance of free GFP ( Supplementary Information, Fig. S1 ). Representative assays in which the ORF library was tested against each reporter alongside appropriate controls are shown in Fig. 1a . Ubiquitin-GFP and NEDD8-GFP were cleaved almost completely by a construct encoding the N-terminal 325 amino-acid residues of the major tegument protein BPLF1 (hereafter termed BPLF1). Additional ORFs showed inefficient cleavage of these reporters, and none cleaved the ISG15, SUMO-1, SUMO-2 and SUMO-3 reporters.
The N terminus of BPLF1 encodes the EBV homologue of a conserved herpesvirus cysteine protease 21 . Because other members of this family had been shown to act preferentially as ubiquitin-specific proteases, we first examined whether BPLF1 is a true deneddylase. The activity of purified GST-BPLF1 against the fluorogenic substrates ubiquitin-AMC (where AMC is 7-amino-4-methylcoumarin) and NEDD8-AMC was tested alongside a mutant in which the catalytic Cys 61 was replaced by Ala (BPLF1 C61A ), the NEDD8-specific protease NEDP1 (ref. 22 ) and its catalytic mutant NEDP1 C163S . Ubiquitin-AMC and NEDD8-AMC were hydrolysed by BPLF1, whereas NEDP1 hydrolysed only NEDD8-AMC, as expected. BPLF1 and NEDP1 showed comparable K m and k cat values for NEDD8-AMC, suggesting similar affinities for the substrate (Fig. 1b) . Hydrolysis was abrogated by the cysteine protease inhibitor N-ethylmaleimide (NEM) and by mutation of the catalytic cysteine. To test whether BPLF1 can hydrolyse true NEDD8 conjugates, a V5-tagged NEDD8 was expressed in HeLa cells and conjugates were captured on anti-V5-Sepharose beads. Equal amounts of beads were incubated with purified GST-BPLF1 in the presence or absence of NEM or, as controls, with purified GST and GST-BPLF1 C61A (Fig. 1c) . Only wild-type BPLF1 hydrolysed the NEDD8 conjugates as detected in western blots probed with the anti-V5 antibody. As expected, ubiquitin conjugates were also cleaved ( Supplementary Information, Fig. S2 ).
Having confirmed the capacity of recombinant BPLF1 to act as a deneddylase in vitro we examined whether the activity is retained by eukaryotic-expressed BPLF1. Lysates of HeLa cells expressing Flag-BPLF1 and Flag-BPLF1 C61A were labelled with the functional probes ubiquitin-VS and NEDD8-VS (where VS is 3-vinyl-(methyl)-sulphone), which form covalent adducts with the catalytic cysteine residue 23 . As illustrated in Fig. 1d , in which activity is revealed by a shift of the specific band corresponding to the size of the probe, BPLF1 bound ubiquitin and NEDD8 with comparable efficiency over a wide range of concentrations, whereas binding was abolished in the catalytic mutant. We finally tested whether BPLF1 acts as a deneddylase in vivo. Flag-tagged BPLF1, NEDP1 and their catalytic mutants were co-transfected in HeLa cells together with V5-NEDD8, and the presence of conjugates was assayed in western blots with the anti-V5 antibody (Fig. 1e) . A comparable decrease in NEDD8 adducts was observed in cells expressing BPLF1 and NEDP1, whereas the catalytic mutants had no effect. Taken together, these data demonstrate that the N terminus of the EBV major tegument protein BPLF1 encodes a cysteine protease with specificity for NEDD8 conjugates in vitro and in vivo.
BPLF1 binds to cullins and inhibits the activity of CRLs
Cullins are the best-characterized substrates of NEDD8 conjugation. We therefore examined whether BPLF1 acts as a cullin deneddylase. Myc-tagged versions of two representative members of this family, Cul1 and Cul4A, were co-transfected in HeLa cells together with V5-NEDD8 and Flag-BPLF1, Flag-BPLF1 C61A or Flag-NEDP1. Cell lysates were immunoprecipitated with an anti-Myc antibody, and western blots were probed sequentially with anti-Myc and anti-V5 antibodies (Fig. 2a) . Slowly migrating species corresponding to neddylated cullins, confirmed by reactivity with the anti-V5 antibody (Fig. 2a , lower panel), were detected when the proteins were expressed alone or together with BPLF1 C61A , whereas the neddylated species disappeared in the presence of BPLF1 and NEDP1.
To investigate whether the enzymes interact with their substrates, lysates of HeLa cells co-transfected with Myc-tagged cullins and Flagtagged enzymes were immunoprecipitated with the anti-Myc or antiFlag antibodies. Sequential probing of western blots revealed a strong interaction of BPLF1 with both cullins, whereas NEDP1 interacted only very weakly (minor co-precipitated species are indicated by asterisks in Fig. 2b ). The interaction of BPLF1 with cullins was independent of its catalytic activity and was not affected by the omission of NEM from the lysis buffer, suggesting that it does not involve binding to NEDD8. To test whether BPLF1 also interacts with endogenously expressed cullins, Cul4A was immunoprecipitated from lysates of HeLa cells transfected with Flag-vector, Flag-BPLF1 and Flag-BPLF1 C61A , and western blots were sequentially probed with anti-Flag, anti-Cul4A and, as control, anti-Myc antibodies (Fig. 2c ). Both the active and catalytic mutant BPLF1 were detected in the immunoprecipitates, whereas c-Myc was not, confirming the specificity of the interaction. Because neddylation activates CRLs we then asked whether BPLF1 modulates the activity of CRLs in vivo. Flag-BPLF1 and Flag-BPLF1 C61A were transfected in HeLa cells and the expression of CDT1 (CRL4-DDB1 CDT2 and CRL1 Skp2 substrate 24 ), Cdc25A (CRL1 βTrCP substrate 25 ), p21 and p27 (CRL1 Skp2 substrates 26 ) was assayed in western blots. Strong accumulation was observed in cells expressing the active enzyme (Fig. 2d) but not in those expressing the catalytic mutant ( Supplementary  Information, Fig. S3 ). This was reversed in a dose-dependent manner by co-expression of V5-NEDD8, in parallel with reconstitution of cullin neddylation (Fig. 2d) . A V5-NEDD8-VV mutant that lacks the carboxy-terminal Gly residue required for conjugation had some effect only at the highest plasmid concentrations when faint cullin-NEDD8 bands were also detected, whereas haemagglutinin (HA)-tagged ubiquitin had no effect.
BPLF1 deregulates S-phase DNA synthesis
The binding to cullins and selective inhibition by overexpression of NEDD8 are consistent with the possibility that BPLF1 may act as a deneddylase in vivo. This was investigated by expressing BPLF1 in a range of cell types. The wild-type and mutant BPLF1 showed a predominant nuclear localization in transfected HeLa cells (Fig. 3a) and in other cell lines tested, including HEK293 and Chinese hamster ovary (not shown). The active enzyme induced a marked increase in the size of the nucleus (Fig. 3a, lower panel) and, on prolonged expression, extensive cell death. To explore the cause of nuclear enlargement, the cell cycle profile and DNA content were assessed by staining with propidium iodide (PI; Fig. 3b ). Expression of BPLF1 was associated with a decrease in the number of cells in G1 stage and an increase in cells with a DNA content of 4N or more. More than 80% of the transfected cells showed a DNA content of 4N or more within 48 h, and the remaining cells showed signs of apoptosis (DNA content less than 2N; Fig. 3b, lower panel) . Almost all the BPLF1-expressing cells were dead within 4-5 days after transfection. This phenotype was reversed in a dose-dependent manner by overexpression of NEDD8 but not by overexpression of ubiquitin (Fig. 3c) .
The accumulation of cells with a DNA content of 4N or more suggests that BPLF1 may cause deregulation of the S phase and re-replication of cellular DNA. Consistent with this possibility, expression of the active enzyme was associated with accumulation of the CRL1 Skp2 substrate E2F1 (ref. 27 ) and its downstream targets cyclin E and cyclin A (Fig. 4) . Furthermore, phosphorylated Cdc6 and CDT1 were increased, whereas the CDT1 inhibitor geminin was decreased, suggesting enhanced licensing of DNA replication origins. DNA re-replication induces DNA damage and elicits DNA-damage responses that halt progression of the cell cycle 28 . DNA damage was revealed by the accumulation of phosphorylated histone H2AX. However, the ATR (ataxia telangiectasia and rad-3-related) kinase and its downstream target Chk1 were not phosphorylated, and Cdc25A, which is targeted for degradation after phosphorylation by Chk1 (ref. 25) , was strongly stabilized, suggesting failure of the intra-S-phase checkpoint 29 . Enhanced phosphorylation of ATM and its downstream targets Chk2 indicated activation of the G2 checkpoint 30 , whereas the failure to accumulate phosphohistone H3 confirmed that BPLF1-expressing cells did not undergo transition into mitosis 31 . Taken together, these findings indicate that BPLF1 induces DNA re-replication, which correlates with the stabilization of several CRL substrates that regulate DNA synthesis and cell cycle progression.
BPLF1 is required for efficient EBV DNA replication
The contribution of the cellular DNA replication machinery to herpesvirus replication is poorly understood. To assess whether the pseudo-Sphase induced by BPLF1 has any function, we used the Akata-Bx1 cell line, which carries a recombinant EBV in which the thymidine kinase gene has been replaced with GFP We first examined whether the productive virus cycle is associated with cellular DNA re-replication. EBV-negative Akata and Akata-Bx1 cells were treated with anti-IgG, followed by monitoring of virus reactivation and cell cycle distribution by GFP fluorescence and staining with PI. Treatment with anti-IgG did not affect the cell cycle in Akata cells, whereas EBV reactivation was accompanied by a marked increase in the number of cells with a DNA content of 4N or more in Akata-Bx1 cells (Fig. 5a ), reaching more than 80% of the live cell population within 72 h (Fig. 5b) .
To exclude a possible contribution of newly synthesized viral DNA, the anti-IgG treatment was repeated in the presence of the herpesvirus DNA polymerase inhibitor Foscarnet 34 . Treatment with Foscarnet abolished EBV DNA replication (Fig. 5c ) but did not affect the re-replication of cellular DNA (Fig. 5d) . Furthermore, induction of the productive virus cycle was accompanied by the accumulation of CDT1, pATM, pH 2AX and Cdc25A and a failure to accumulate phosphohistone H3 (Fig. 5e) .
Although BPLF1 is a virion component, expression of the messenger RNA was detected by quantitative polymerase chain reactions (qPCRs) specific for the N-terminal and C-terminal domains of the transcript within few hours after triggering by anti-IgG ( Supplementary  Information, Fig. S4 ). This kinetics of expression is reminiscent of that of early genes that are induced by BZLF1 and mediate replication of the EBV genome 35 . To test whether BPLF1 regulates EBV replication, its expression was inhibited by transducing anti-IgG-treated Akata-Bx1 cells with recombinant lentiviruses expressing specific short hairpin RNAs (shRNAs) (shBP1) and, as controls, shRNAs to BZLF1 (shBZ1) or a scrambled shRNA ( Supplementary Information,  Fig. S5 ). The scrambled shRNA did not affect EBV reactivation as detected by expression of the immediate-early protein BZLF1, the early protein BORF2 and the late proteins gp220-350, whereas full inhibition was achieved by BZLF1 knockdown, as expected (Fig. 6a ). The expression of viral proteins was not affected by BPLF1 knockdown (Fig. 6a) . However, the accumulation of cells with a DNA content of 4N or more was abrogated (Fig. 6b) , which was correlated with an almost complete inhibition of virus DNA replication (Fig. 6c) . Thus, BPLF1 seems to act downstream of BZLF1 to promote efficient replication of the EBV genome.
EBV replication is dependent on overexpression of CDT1
We then sought to identify which among the cellular products regulated by BPLF1 is required for EBV DNA replication. Because overexpression of CDT1 causes cellular DNA re-replication 36 , we tested whether BPLF1 is required for the accumulation of CDT1 in cells entering the productive virus cycle. Transduction of antiIgG-treated Akata-Bx1 cells with the shBZ1 lentivirus abolished the accumulation of CDT1; a comparable inhibition was observed with the shBP1 lentivirus, confirming that BPLF1 regulates the abundance of this CRL substrate during productive infection (Fig. 7a) . Overexpression of CDT1 partly reconstituted the cellular DNA rereplication phenotype induced by BPLF1 knockdown (Fig. 7b) . Most significantly, although overexpression of CDT1 did not affect EBV DNA replication either alone or in the absence of BZLF1 (Fig. 7c) , it reconstituted virus production in BPLF1 knockdown cells. Taken together, these data demonstrate that stabilization of CDT1 is critical for the induction of an S-phase-like environment that is permissive of virus replication.
Deneddylase activity of BPLF1 homologues
We finally tested whether the deneddylase activity and induction of cellular DNA re-replication are conserved among BPLF1 homologues encoded by other herpesviruses. GST fusions of the N termini of HSV-UL36 and MCMV-M48 were assayed for cleavage of the ubiquitin/UbL-GFP reporters in bacteria co-expression assays. The ubiquitin and NEDD8 reporters were cleaved with comparable efficiency (Fig. 8a) . Furthermore, Flag-tagged viral proteins retained the capacity to bind NEDD8-VS when expressed in HeLa cells (Fig. 8b) , and overexpression was associated with an accumulation of cells with a DNA content of 4N or more, comparable to that achieved by overexpression of BPLF1 (Fig. 8c) . Thus, both deneddylase activity and S-phase deregulation seem to be conserved in this family of viral enzymes.
DISCuSSIoN
Pathogenic viruses and intracellular bacteria have evolved elaborate strategies for manipulating the ubiquitin and UbL signalling machineries, including the production of functional homologues of cellular enzymes. Here we discovered that a conserved cysteine protease encoded in the N terminus of the major tegument protein of herpersviridae acts in vivo as a NEDD8-specific protease that binds to cullins and regulates the turnover of CRL substrates. Expression of this viral deneddylase is associated with deregulation of the cell cycle and with the establishment of an S-phase-like environment that is required for efficient replication of the viral genome. HSV-UL36
MCMV-M48
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Probe ng On the basis of in vitro assays performed with fluorogenic substrates, branched peptides and functional probes, it was suggested that UL36, the HSV1-encoded founding member of this family of viral enzymes, and other homologues including BPLF1, preferentially cleave ubiquitin adducts 21 . Our data confirm the capacity of EBV-BPLF1, HSV-UL36 and MCMV-M48 to cleave ubiquitin conjugates but demonstrate that they cleave NEDD8 adducts with comparable efficiency (Fig. 8) . Most significantly, we have shown that BPLF1 is capable of hydrolysing true NEDD8 conjugates in vitro and in transfected cells (Fig. 1) . Given the high degree of homology between ubiquitin and NEDD8 this dual specificity is not surprising and is indeed shared by many ubiquitin-specific proteases 3 . It is noteworthy that the exquisite specificity of NEDP1 for NEDD8 adducts was attributed to the presence of bulky residues in the catalytic cleft that restrict the access of ubiquitin 37 . The large Arg 72 residue in the C terminus of ubiquitin is replaced by Ala in NEDD8, which may allow accommodation of the slender C terminus into a broader range of catalytic clefts. On the basis of the crystal structure of MCMV-M48 crosslinked to ubiquitin-vinylmethyl ester (VME) it was proposed that a hydrogen bond between Arg 72 and Thr 80 in MCMV-M48 may be crucial for the binding of ubiquitin, and lack of this interaction was implicated in the failure to bind NEDD8-VME 38 . We have used a different NEDD8 probe, namely NEDD8-VS. Conceivably, the presence of a glycine-VS reactive group, rather than glycine-VME, could explain the different reactivity of MCMV-M48. Indeed, previous reports have documented differences in the crosslinking efficiency of various ubiquitin functional probes, including failure of ubiquitin-VME to recognize the ubiquitin protease OTUB1 (ref. 39) .
Although the double specificity of BPLF1 for both ubiquitin and NEDD8 was documented in a range of in vitro assays, several lines of evidence suggest that the deneddylase activity may have a dominant function in vivo. BPLF1 binds to and deneddylates cullins and induces the stabilization of several CRL substrates. The capacity to interact tightly with cullins is a unique feature of BPLF1 and, together with its nuclear localization, suggests that the enzyme may specifically target this group of NEDD8 substrates. The finding that stabilization of CRL substrates, such as CDT1, Cdc25A, p21 and p27, was efficiently counteracted by overexpression of NEDD8 but not that of NEDD8-VV or ubiquitin further supports the key role of cullin deneddylation. Although both ubiquitin and NEDD8 are abundantly expressed in cells, the effect of NEDD8 overexpression indicates that the neddylation cycle may be tightly regulated and may be critically dependent on local concentrations of the modifier. Most significantly, the phenotype of BPLF1 overexpression is consistent with the selective stabilization of CRL substrates that control DNA replication and cell cycle progression. A very similar phenotype is induced in cells treated with MLN4924, a potent inhibitor of the NEDD8-activating enzyme that inactivates the conjugation cascade 40 . A surprising difference between the effect of BPLF1 and MLN4924 is the failure to activate ATR and Chk1 in BPLF1-expressing cells. The mechanisms of this selectivity are unclear but may reflect the capacity of the viral enzyme to interact preferentially with a distinct subset of NEDD8 substrates in vivo. Thus, although a contributory effect of deubiquitylation is possible, our findings strongly indicate that the deneddylase activity and the specific targeting to cullins are decisive for the effect of BPLF1 in transfected cells and during EBV reactivation.
The strict human tropism of EBV does not allow a direct assessment of the contribution of BPLF1 to viral infection in vivo. However, evidence from animal herpesviruses confirms that the enzymatic activity of this protein family is important in viral pathogenesis by regulating the yield of infectious virus. Thus, mutations of the catalytic cysteine residue in ORF64 of murine gammaherpesvirus-68 and pUL36 of pseudorabies virus (suid herpesvirus 1) yielded viruses that replicate less efficiently in vitro and are less pathogenic in vivo 41, 42 , whereas a mutation that inactivates the homologue encoded by Marek's disease virus was shown to diminish replication in vivo and severely limit the oncogenic potential of the virus 43 . Our finding that BPLF1, and by inference other homologues, regulates the efficiency of virus replication by contributing to the establishment of an S-phase-like environment provides a new insight into the still poorly understood process of herpesvirus replication. Although increasing evidence implicates viral proteins in the deregulation of the host cell cycle that accompanies viral DNA synthesis, the mechanisms and possible contribution of cellular factors remain largely unknown 44 . Notably, although all the components of the DNA polymerases of herpesviruses are known, the reconstituted enzymes are poorly active in vitro, suggesting that cellular processivity factors may be missing 45 . Our finding that BPLF1 promotes EBV DNA replication by stabilizing CDT1 points to this and possibly other components of the cellular DNA-replication licensing machinery as likely candidates.
METHoDS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/ DoI: 10.1038/ncb2035
Antibodies. The following antibodies were used: anti-S-tag (71549-3, 1:6000, Novagen, Darmstadt, Germany); anti-V5 (R960-25, 1:2500, Invitrogen, Carlsbad, CA); anti-β-actin and anti-Flag (AC-15 1:5000, F-3165 1:8000, Sigma, St Louis, MO); anti-p27/Kip1 and anti-human IgG (M7203 1:1000, A0423 1:50, DAKO, Denmark); anti-p21/Cip1/WAF1 (610233 1:1000, BD Biosciences); anti EBV EA-R (BORF2, sc-56979 1:1000), BZLF1 (sc-53094 1:1000), ATR (sc-28091 1:1000), E2F-1 (sc-251 1:1000), geminin (sc-13015 1:1000), cyclin-E (sc-20684 1:1000), cyclin-A (sc-751 1:1000), cyclin-B1 (sc-245 1:1000), Cdt1 (sc-28262 1:1000), p53 (sc-126 1:1000), c-Myc (sc-40 1:3000), Cdc25A (sc-7157 1:1000), phospho-Cdc6-S54 (sc-12970-R 1:1000) from Santa Cruz Biotechnogy, Santa Cruz CA; anti-retinoblastoma (Rb) (SA-124 1:1000, Enzo, Life Sciences, PA); anti-phospho-Chk2-T68, phosphoChk1-S345 1:1000, phospho-ATR-S428, anti-phospho-H3-S10 1:1000 all from Cell Signalling, Danvers, MA; anti-phospho-ATM-S1981 (NB100-306 1:1000, Novus Biologicals, Littleton, CO); anti-ATM and anti-Cullin4A (ab-34897 1:1000, ab-2618 1:3000, AbCam, Cambridge, MA); anti-phospho-H2AX-S139 1:1000 (Millipore Corporation, Billerica, MA); anti-EBV gp220/350 1:100 and EBNA1 (OT1-X 1:1000) (gifts of Jaap M. Middeldorp, CCA-VUMC, Amsterdam, The Netherlands).
Plasmids. The GST-BPLF1 (amino-acid residues 1-325) and ubiquitin-GFP plasmids were described previously 20 . The coding sequences of NEDD8, ISG15, SUMO-1, SUMO-2 and SUMO-3 were cloned in frame with GFP into the BglII and XhoI sites of the GFP-S-tag-pACYCDuet-1 plasmid (Novagen). Bacterial and eukaryotic expression plasmids encoding residues 1-290 of HSV1-UL36 and residues 1-315 of MCMV-M48 were cloned in the pDEST-GST Flag-tag vectors.
Immunoblots. The cells were lysed in buffer (25 mM Tris-HCl pH 7.6, 50 mM NaCl, 1 mM EDTA, 0.5% Nonidet P40, 0.1% SDS, 0.5% sodium deoxycholate) containing protease inhibitors (Complete Mini Protease Inhibitor Cocktail tablets; Roche) and 10 mM NEM (Sigma), and protein concentration was measured with a Protein Assay kit (Bio-Rad Laboratories). Equal amounts of proteins were fractionated in a polyacrylamide Bis-Tris 4-12% gradient or in polyacrylamide Tris-acetate 7% linear precast gels (Invitrogen). After transfer to poly(vinylidene difluoride) membranes (Millipore), the filters were blocked in PBS saline buffer containing 5% non-fat milk and 0.1% Tween 20 and incubated with primary antibodies either for 1 h at 24°C or overnight at 4 °C followed by incubation for 1 h with the appropriate horseradish peroxidase-conjugated secondary antibodies. The complexes were revealed by chemiluminescence (ECL; GE Healthcare). . Recombinant plasmids were co-transfected with the packaging plasmids psPAX2 and pMD2.G (Addgene; EPFL) in HEK293T cells by precipitation with calcium phosphate, and supernatant containing viral particles was collected after 48 h. Virus titres were measured with a QuickTiter lentivirus titre kit (Cell Biolabs Inc.).
RT-PCR
Screen for EBV deconjugases. The deconjugase activity of an EBV ORF library cloned in the pDEST-GST vector was assayed by co-expression with ubiquitin/ UbL-GFP reporters in competent BL21 bacteria as described 20 . GST fusions of the ubiquitin-specific deconjugase USP19 (ref. 47) , the ISG15 deconjugase USP4 (ref. 48) , the NEDD8 deconjugase NEDP1 (ref. 22 ) and the SUMO-1, SUMO-2 and SUMO-3 deconjugase SENP1 (ref. 49) were used as positive controls. Exponentially growing bacteria were induced for 5 h at 30 °C with 0.5 mM isopropyl β-d-thiogalactoside and then lysed by sonication in PBS supplemented with protease inhibitors. After normalization for GFP content the lysates were fractionated by SDS-PAGE and cleavage of the reporters was assessed in western blots with anti-S-tag antibody. The intensity of the GFP bands was quantified by densitometry and the percentage cleavage was calculated as the ratio between the intensity of the free GFP band and the total GFP. Each screen was repeated at least twice.
Deconjugase activity assays. GST fusions of BPLF1, a catalytically inactive BPLF1 C61A mutant, NEDP1 and the catalytic mutant NEDP1 C163S were affinitypurified and protein concentrations were determined. Hydrolysis of the fluorogenic substrates ubiquitin-AMC and NEDD8-AMC (Enzo) was assayed at 30 °C in 100 µl of buffer (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM dithiothreitol) containing 50 nM enzyme. K m and k cat were calculated by titrating the substrate at concentration ranging between 0 and 20 µM. The enzymatic activity was blocked by addition of 10 mM NEM. NEDD8 conjugates were purified from lysates of HeLa cells transfected with a V5-NEDD8 plasmid by adsorption on anti-V5-conjugated Sepharose beads. Equal amounts of beads were incubated with 200 nM enzymes for 1 h at 37 °C, and western blots were probed with anti-V5 antibodies. The enzymatic activity of eukaryotic expressed BPLF1 was assayed by labelling lysates of transfected HeLa cells with the ubiquitin-VS and NEDD8-VS functional probes (Boston Biochem) as described 23 . Cell lysate (5 µg) was incubated for 1 h at 37 °C with increasing concentration of the probe. Unmodified and ubiquitin/NEDD8-VS crosslinked species were detected in western blots by using the anti-Flag antibody. In vivo deneddylase activity was assayed in HeLa cells co-transfected with V5-NEDD8 and Flag-tagged BPLF1, NEDP1, BPLF1 C61A and NEDP1 C163S . The transfected cells were harvested after 48 h, and NEDD8 conjugates were detected in western blots by using the anti-V5 antibody.
Cullin neddylation and co-immunoprecipitation assays. The coding sequences of human cullin-1 and cullin-4A were subcloned in the BamH1 and Not1 sites of the pcDNA4/Myc vector (Invitrogen). Cullin deneddylation was assayed in HeLa cells co-transfected with the Myc-tagged cullins, V5-NEDD8 and Flag-BPLF1, Flag-BPLF1 C61A or Flag-NEDP1. Cell lysates prepared 48 h after transfection were fractionated by SDS-PAGE, and western blots were probed sequentially with the anti-Myc and V5 antibodies. For co-immunoprecipitation, aliquots of the cell lysates were incubated either for 1 h with the anti-Myc antibody followed by Protein-G-coupled Sepharose beads (GE Healthcare) or for 2 h with anti-Flag agarose affinity gel (A-2220; Sigma) followed by elution with a 3 × Flag peptide (F-4799; Sigma). Western blots were probed sequentially with the anti-Myc and anti-Flag antibodies. Interaction with endogenous cullins was assayed by immunoprecipitation of cell lysates of HeLa cells transfected with empty vector, Flag-BPLF1 and Flag-BPLF1 C61A with anti-Flag and anti-Cull4A antibodies.
Immunofluorescence and cell cycle analysis. The subcellular localization of Flag-BPLF1 and Flag-BPLF1 C61A was investigated by immunofluorescence. HeLa cells were grown on coverslips and transfected with the jetPEI Kit (Polyplus Transfection). After 48 h the monolayers were fixed with 4% paraformaldehyde and permeabilized for 20 min with 0.5% v/v Triton X-100 in PBS. Staining with the anti-Flag antibody (didilution 1:5,000 in PBS containing 0.5% BSA) was performed for 2 h at room temperature followed by incubation for 1 h with tetramethylrhodamine β-isothiocyanate-conjugated anti-mouse immunoglobulin antibodies (1:200 dilution; R0270; Dako). Cytoskeletal actin was stained with FITC-labelled phalnature cell biology loidin (1:100 dilution; P-5252; Sigma). The slides were mounted with Vectashield containing DAPI (H-1200; Vector Laboratories) and images were captured with a Leica DM RXA fluorescent microscope and analysed with the Improvision OpenLab 3.1.4 software (http://www.improvision.com). Nuclear size was measured with the ImageJ software (http://rsbweb.nih.gov). For staining with PI, the cells were fixed for 1 h in cold 70% ethanol and stained for 45 min in ice-cold staining solution (50 mg ml −1 PI, 25 mg ml −1 RNase A, 1 mg ml −1 sodium citrate, 0.3% Nonidet P40). DNA content was measured by fluorescence-activated cell sorting (FACS) with a FACSCalibur (Becton Dickinson) and analysed with CellQuestPro software. Where indicated, the cells were co-transfected with 2 µg of the BPLF1 plasmid and increasing amounts of either the HA-ubiquitin or the V5-NEDD8 plasmids for 48 h before being stained with PI.
Induction of the EBV productive cycle and quantification of viral DNA. The productive virus cycle was induced in the Akata Bx-1 cell line that carries a recombinant EBV in which the thymidine kinase gene is replaced by a cytomegalovirus (CMV) immediate-early promoter-driven GFP, by incubating cell pellets for 1 h at 37 °C with polyclonal rabbit anti-human IgG 32 . EBV DNA content was assayed by qPCR with probes specific for unique regions in the genes encoding BZLF1 and EBNA1 and the KAPA SYBR FAST qPCR Kit (KK4604; KAPA Biosystems). Where indicated, EBV DNA replication was inhibited by the addition of 50 µM Foscarnet, a herpesvirus DNA polymerase inhibitor 50 . Akata-Bx1 cells were infected with recombinant lentiviruses for 72 h at a multiplicity of infection of 2.55 × 10 10 in the presence of 8 mg ml −1 Polybrene (AL-118; Sigma). Where indicated, cells infected for 24 h were treated with anti-human IgG antibody for 48 h before FACS and western blot analysis. A human CDT1 expression plasmid was purchased from OriGene Technologies (SC122393). Expression was assayed in cells transfected with the Cell Line Nucleofector Kit V (AMAXA; Lonza Group) using a specific antibody.
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Figure S1 Western blot analysis of bacteria co-expression assays where GST-BPLF1 was testes for cleavage of the Ub-and UbL-GFP reporters alongside the empty GST vector and the appropriate positive controls (USP19, NEDP1, USP4 and SENP1). Cleavage of the reporter is visualized by the appearance of a free GFP band (GFP) detected by antibodies to the C-terminal S-tag. were preformed on cDNA templates with the specific primers, and GAPDH was used as standard control for the normalization. The products were run in 1.5% agarose gel and the fold increase is plotted on the graphic. 
